Brief: Candel Therapeutics Q1 Net Income USD 7.379 Million
13/05/2025 13:05
May 13 (Reuters) - Candel Therapeutics Q1 operating expenses USD 8.13 million. Q1 basic EPS USD 0.15 Q1 income from operations USD -8.13 million
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)